Insulet to spend up to $40M on Omnipod 5 pod recall - Boston Business Journal

NodeGuardian · 2026-03-22T07:41:23+00:00

Insulet Corp. will spend up to $40 million recalling its Omnipod 5 insulin pump pods due to 18 reports of serious issues from insufficient insulin delivery.

NodeGuardian

2026-03-22 07:41:23

Abstract generation in progress

Insulet Corp. is set to incur costs of up to $40 million for the recall of its Omnipod 5 tubeless insulin pump pods. The Acton-based company initiated the recall after receiving 18 reports of serious adverse events related to insufficient insulin delivery from the devices.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.